Epidemiological and clinical characteristics of COVID-19 in a Brazilian public hospital

Table 3 Age, sex, comorbidities, and laboratory tests associated with the main outcomes, n (%)

Comorbidities	Death, n	Discharged, n	P value	Death, mean ± SD	Discharged median ± SD
Hypertension	33 (53.2)	29 (46.8)	0.15
Diabetes	18 (58.1)	13 (41.9)	0.14
Cardiovascular disease	11 (50.0)	11 (50.0)	0.54
Obesity	6 (50.0)	6 (50.0)	0.58
Chronic kidney disease	8 (66.7)	4 (33.3)	0.15
Chronic obstructive pulmonary disease	2 (50.0)	2 (50.0)	0.67
Autoimmune diseases	0 (0)	1 (100)	0.51
At least 2 comorbidities	28 (60.9)	18 (39.1)	0.01
Laboratory tests
Hemoglobin, mg/dL			0.55	11.31 ± 2.96	11.70 ± 2.79
Leukogram, mm³			0.93	14.448 ± 6.878	14.292 ± 8.705
CRP, g/L			0.18	143.46 ± 150.76	147.53 ± 201.60
Platelets, g/L			< 0.001	141.49 ± 9.55	154.88 ± 72.91
Serum sodium, mEq/L			0.35	143.00 ± 9.79	140.62 ± 10.70
AST, U/L			0.22	54.20 ± 32.41	92.83 ± 24.10
ALT, U/L			0.7	26.00 ± 13.78	81.90 ± 90.50
Lactic dehydrogenase, U/L	486.00 ± 48.08	274	0.17

CRP: C-reactive protein; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; SD: Standard deviation.